Status:

COMPLETED

Use of Antiretroviral (ARV) Drug Levels in Dried Blood Spots (DBS) to Assess and Manage ART Adherence in South Africa

Lead Sponsor:

New York State Psychiatric Institute

Collaborating Sponsors:

Research Foundation for Mental Hygiene, Inc.

Desmond Tutu HIV Foundation

Conditions:

Therapeutic Adherence and Compliance

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a prospective, pilot study of HIV-positive individuals who have been on tenofovir-containing antiretroviral therapy for at least 4 months. The overall goal of this research is to determine the...

Detailed Description

This is a prospective, pilot study of HIV-positive individuals who have been on tenofovir-containing antiretroviral therapy for at least 4 months. The overall goal of this research is to determine the...

Eligibility Criteria

Inclusion

  • 18 years of age or older
  • HIV-positive
  • Initiated ARV's containing tenofovir 4 or more months ago
  • Speaks English or Xhosa
  • Willing to attend 5 study visits approximately one month apart
  • Willing to allow the study team to contact his/her HIV care provider about his/her monthly TFV-diphosphate (TFV-DP) drug level
  • Willing to use Wise Pill to dispense ARVs for 4 months
  • Willing to receive text/short message service (SMS) and/or phone call reminders to charge the Wise Pill
  • Willing to allow the study team access to their medical chart/clinic folder

Exclusion

  • Unable to provide informed consent
  • Unwilling to participate in study procedures
  • Unwilling to allow the study team to contact his/her HIV care provider about his/her monthly TFV-DP drug level
  • Any condition that, in the opinion of the principal investigator would make participation in the study unsafe, complicated interpretation of study outcome data, or otherwise interfere with achieving the study objectives.

Key Trial Info

Start Date :

September 18 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 29 2022

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04333498

Start Date

September 18 2020

End Date

November 29 2022

Last Update

January 20 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

1051 Riverside Drive

New York, New York, United States, 10032

2

Gugulethu Clinic

Cape Town, Western Cape, South Africa, 7750